Metraipolis › archive › dc_7054b7814a67

The SPA17-AXL axis drives melanoma aggressiveness and SPA17-targeting vaccination exhibits antitumor efficacy — Europe PMC PMID:42780548

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42780548
DOI
10.3389/fimmu.2026.1914680
License (as archived)
solo-consultazione
Archived
2026-10-15T22:37:23.798Z
SHA-256 of the archived text
3a0516ecd7ad36772e6ea9b16dd4626538a6f3b82fb61ab4c17e5a3f57ada253
Stable URL of this page
https://metraipolis.com/documento/dc_7054b7814a67

How to cite

The SPA17-AXL axis drives melanoma aggressiveness and SPA17-targeting vaccination exhibits antitumor efficacy — Europe PMC PMID:42780548 — Europe PMC (en), https://europepmc.org/article/MED/42780548 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7054b7814a67 (Metraipolis archive dc_7054b7814a67, sha256 3a0516ecd7ad36772e6ea9b16dd4626538a6f3b82fb61ab4c17e5a3f57ada253)
BibTeX
@misc{dc7054b7814a67,
  title = {The SPA17-AXL axis drives melanoma aggressiveness and SPA17-targeting vaccination exhibits antitumor efficacy — Europe PMC PMID:42780548},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42780548},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7054b7814a67; sha256 3a0516ecd7ad36772e6ea9b16dd4626538a6f3b82fb61ab4c17e5a3f57ada253},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42780548. Agents can read the archived copy with the MCP tool read_document.